Entrada Therapeutics, Inc. (TRDA)

Entrada Therapeutics Revenue

In the year 2024, Entrada Therapeutics had annual revenue of $210.78M with 63.38% growth. Entrada Therapeutics had revenue of $37.40M in the quarter ending December 31, 2024, a decrease of -10.63%.

• Revenue (ttm): $210.78M
• Revenue Growth: +63.38%
• P/S Ratio: 1.57
• Revenue / Employee: $1,151,814
• Employees: 183
• Market Cap: 312.80M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	210.78M	81.77M	63.38%
Dec 31, 2023	129.01M	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.